Craniomaxillofacial Implants Market Size, Share and Global Trend By Product (Screws, Mesh, Plates, Bone Graft, Dural Repair, Others), By Material (Titanium, Polymers, Others), By End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others) and Regional Forecast, 2024-2032

Craniomaxillofacial surgeries are performed in order to treat diseases, injuries, defects, and abnormalities associated with head, neck, cranial space, and face. The craniomaxillofacial implant offers replacements and restoration of dysfunctional or missing anatomical structures in order to improve the function of defective craniomaxillofacial parts. Commonly observed craniomaxillofacial abnormalities include cleft lip, hemifacial macrosomia, craniosynostosis, hemangiomas, vascular malformations, and cleft palate.

Craniomaxillofacial abnormalities adversely affect eating habits, difficulties in speech and language, hearing loss, and dental problems. The craniomaxillofacial implant includes plates, meshes, screws, and other instruments. The emerging applications of certain software such as CAD (computer-aided design and drafting)/ CAM (Computer-aided manufacturing) for designing and manufacturing of craniomaxillofacial implants are likely to offer greater precision to the care providers.

Global craniomaxillofacial implants market growth is being driven by the escalating incidence of craniomaxillofacial abnormalities in new born and rising number of craniomaxillofacial injuries due to accidents. Combined with this, growth in adoption of craniomaxillofacial implants for aesthetic purpose in developed nations is expected to boost the demand for craniomaxillofacial implants during the forecast period. According to the American Society of Craniofacial Surgeons, an estimated 1 in 1000 babies in born with cleft palate each year in the U.S., which is anticipated to boost the demand for craniomaxillofacial implants.

However, lack of craniomaxillofacial surgeons and proper healthcare infrastructure in emerging nations may hamper the growth in the global craniomaxillofacial implants market. 

Key Players Covered:

Some of the major companies that are present in the global craniomaxillofacial implants market report include Stryker, Medtronic, Integra LifeSciences, DePuy Synthes, Integer Holdings Corporation, KLS Martin Group, Medartis, Zimmer Biomet, B. Braun Melsungen AG, MATRIX SURGICAL USA, Rebstock Instruments GmbH, OsteoMed, Materialise, Johnson & Johnson Services, Inc., CONMED Corporation, Calavera Surgical Design, and others.

SEGMENTATION

As per the current craniomaxillofacial implants market trends, the titanium segment among the material is anticipated to hold a considerable share of the global craniomaxillofacial market during the forecast period owing to the high preference of titanium for manufacturing of implants, higher strength, and resistant to degradation.

Key Insights

• Number of Craniomaxillofacial Procedures


• Regulatory Scenario for Key Countries


• Reimbursement Scenario for Key Countries


• Pricing Analysis


• Recent Industry Developments Such as Partnerships, Mergers, And Acquisitions

Regional Analysis

The global craniomaxillofacial implants market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global craniomaxillofacial implants market over the forecast period owing to the rise in craniomaxillofacial disorders, favourable health reimbursement, and rapid adoption of 3D printing technology in the manufacturing of implants. The craniomaxillofacial market in Europe is expected to expand with considerable CAGR during the forecast period owing to new product launch and increasing incidences of sports injuries. Asia Pacific and Middle East & Africa are likely to leverage huge potential for growth of the global craniomaxillofacial implants market owing to the growing awareness regarding external and internal implants, increased healthcare investment, and active government support.

Craniomaxillofacial Implants Industry Developments

• In May 2019, Kelyniam Global Inc. received premarketing approval from the FDA that will allow the company to make unique modifications in their PEEK cranio-maxillofacial implant products.
• In June 2018, Renishaw showcased its craniomaxillofacial implants which were developed using additive manufacturing technology at British Association of Oral and Maxillofacial Surgeons (BAOMS) Annual Scientific Meeting.
• In September 2017, DePuy Synthes Companies announced the launch of TRUMATCH Titanium 3D-Printed Implants in the U.S. for fascial reconstruction procedures.